Fingerprint

Dive into the research topics of 'Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science